Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of First-Line Antiretrovirals in Healthy Breastfeeding Volunteers
NCT05648201Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doravirine, bictegravir, emtricitabine, tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by Radboud University Medical Center. Started Mar 2023; status: completed.
02
Drugs
doravirinebictegraviremtricitabinetenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05648201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05648201.